<DOC>
	<DOCNO>NCT02820025</DOCNO>
	<brief_summary>The current study design investigate difference plasma orexin A level doxapram group control group emergence time sevoflurane-remifentanil anesthesia undergo elective lumbar surgery .</brief_summary>
	<brief_title>The Effect Mechanism Respiratory Stimulant Doxapram Facilitating Emergence</brief_title>
	<detailed_description>BACKGROUND : General anesthesia widely use clinic , mechanism fully clear.Delayed emergence general anesthesia happen time time , increase occurrence complication economic burden patient . The analeptic currently use clinic side effect . Recently , study show orexin facilitate emergence general anesthesia.Because complex chemical structure difficulty synthetic process , mountain work need do use clinic . Doxapram widely use respiratory stimulant patient . Recently investigator find patient intravenous injection doxapram would shorten emergence time general anesthesia , associate mechanism unclear . Based previous discovery injection doxapram patient could increase plasma level orexin - A , investigator hypothesize doxapram probably facilitate emergence general anesthesia promote release orexin . DESIGNING : Forty patient ASA physical status I II schedule elective lumbar surgery general anesthesia ( last 2h 4h ) enrol . Anesthesia induce propofol 1-2mg/kg sufentanyl 0.2-0.3μg/kg . Following muscle relaxation iv cisatracurium besylate 0.2mg/kg endotracheal intubation perform . Anesthesia maintain sevoflurane ( inhalational concentration : 0.8-2.0 MAC ) target control infusion remifentanil ( target concentration:2-6ng/ml ) along oxygen/air mixture ( FiO2 =0.5 ) . Muscle relaxation maintain intermittent . Inhalational concentration sevoflurane inject target concentration titrate maintain bispectral index ( BIS ) 40 60 anesthesia . The end-tidal carbon dioxide level maintain 30 40 mmHg control mechanical ventilation . When surgery complete investigator adjust concentration sevoflurane 0.8MAC patient target concentration remifentanil 2ng/ml stop anesthetic adjust oxygen flow 6.0 L/min , time doxapram group iv doxapram 1mg/kg , control group give equal volume saline . Record time stop anesthetic emergence . Arterial blood ( 2ml ) collect following time , 1h induction anesthesia , emergence ( 1 min tracheal extubation ) half hour tracheal extubation . This centrifuged 3000 rpm 15min −4 ◦C order separate plasma store −80 ◦C assay orexin A concentration . EXPECTED RESULTS : The plasma orexin A doxapram group high emergence time shorter control group .</detailed_description>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<mesh_term>Doxapram</mesh_term>
	<mesh_term>Respiratory System Agents</mesh_term>
	<criteria>1 . Participant Adult ( ≥18 year old ≤75 year old ) 2 . Participants Body Mass Index ( BMI ) 2025 kg/m2 3 . Participants ASA physical status Ⅰor Ⅱ 4 . Participants Heart function rating Ⅰor Ⅱ 5. patient undergo elective lumbar surgery general anesthesia 6 . The operation time 2h 4h . 1 . Participant pregnant woman nurse mother . 2 . Participants history narcotic allergic reaction . 3. index liver kidney function twice high normal . 4 . Participants history diagnosis depression . 5 . Participants history Brain Trauma . 6 . Participants history narcotic addiction drug addiction . 7 . Participants family International Classification Sleep Disorders diagnosis obstructive sleep apnea syndrome . 8. patient refuse trail able sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>